Antibiotics Are a Politically Difficult Sell on Capitol Hill
Antibiotic resistance is growing, but research into new drugs has dwindled. Experts say Congress needs to enact policies so that Medicare pays more for these critical drugs.
You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.
